179 related articles for article (PubMed ID: 1441428)
1. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
Liashenko VA; Iuminova NV; Krasnova VP
Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
[TBL] [Abstract][Full Text] [Related]
2. [The specific activity and immunological safety of the intranasal method of revaccination with a live measles vaccine made from the Leningrad-16 strain].
Iuminova NV; Krasnova VP; Liashenko VA; Vedunova SL
Vopr Virusol; 1993; 38(3):111-3. PubMed ID: 7521099
[TBL] [Abstract][Full Text] [Related]
3. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
Liashenko VA; Krasnova VP; Youminova NV
Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
[TBL] [Abstract][Full Text] [Related]
4. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
Dilraj A; Cutts FT; Bennett JV; Fernandez de Castro J; Cohen B; Coovadia HM
Pediatr Infect Dis J; 2000 Dec; 19(12):1211-3. PubMed ID: 11144388
[No Abstract] [Full Text] [Related]
5. [Intranasal revaccination of children with live measles vaccine: development of local immunity].
Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS
Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436
[TBL] [Abstract][Full Text] [Related]
6. [The immunological indices in the intranasal method of revaccination with a live measles vaccine].
Iuminova NV; Krasnova VP; Liashenko VA
Vopr Virusol; 1993; 38(4):182-4. PubMed ID: 8236946
[TBL] [Abstract][Full Text] [Related]
7. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
[TBL] [Abstract][Full Text] [Related]
8. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
[TBL] [Abstract][Full Text] [Related]
9. [An intranasal method of revaccination against mumps].
Krasnova VP; Iuminova NV; Liashenko VA
Vopr Virusol; 1994; 39(1):24-6. PubMed ID: 8160444
[TBL] [Abstract][Full Text] [Related]
10. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
11. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
12. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
13. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
[TBL] [Abstract][Full Text] [Related]
14. [Intranasal vaccination with live measles vaccines within the framework of measles eradication strategy].
Liashchenko VA; Iuminova NV
Vopr Virusol; 2002; 47(3):7-10. PubMed ID: 12173439
[TBL] [Abstract][Full Text] [Related]
15. Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections.
Simasathien S; Migasena S; Bellini W; Samakoses R; Pitisuttitham P; Bupodom W; Heath J; Anderson L; Bennett J
Vaccine; 1997 Feb; 15(3):329-34. PubMed ID: 9139495
[TBL] [Abstract][Full Text] [Related]
16. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
[No Abstract] [Full Text] [Related]
18. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
[TBL] [Abstract][Full Text] [Related]
19. Revaccination against measles--a pilot study.
Watson GI; Nichols JA; Robshaw JR
J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
[TBL] [Abstract][Full Text] [Related]
20. [Revaccination against measles].
Gerike E; Kirchner W; Pöhle W; Tischer A
Z Gesamte Hyg; 1983 Feb; 29(2):62-5. PubMed ID: 6858258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
